All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

Private equity firm Knox Lane is selling pharma consultancy Fingerpaint Group, Axios Pro has learned.

Why it matters: Pharma marketing saw steady deal activity in the second half of 2025. 

Zoom in: Houlihan Lokey and Baird are co-mandated to sell the business, which is being marketed on about $65 million of EBITDA.

Fingerpaint provides marketing, branding, and medical communication services to pharmaceutical, biotech, medical device and animal health companies. 

Friction point: The company has made 10 acquisitions since Knox Lane acquired it in 2020, and one source says some prospective buyers are wary of Fingerpaint's integration and organic growth prospects.

State of play: The second half of 2025 was packed with pharma marketing and comms deals. 

BDT and MSD acquired BPD Healthcare last October to roll it into their medical media company portfolio company MJH Life Sciences.

Triton-backed Clinigen paid a high-teens EBITDA multiple for biotech consultancy SSI Strategy in September.

DeepIntent, a platform helping Big Pharma buy ad space, took in $637 million from Vitruvian Partners, also in September.

Advent International acquired PatientPoint, which sells pharma ads in physicians' offices, for north of $1.4 billion in August.

Knox Lane and Baird did not respond to a request for comment. Houlihan declined to comment.

Scoop: Knox Lane-backed Fingerpaint Group on the block

Private equity demonstrated strong interest in pharma marketing investments last year.

Illustration of a heart rate line as if it were an ellipsis within a typing text indicator.

speech bubble with a heartbeat monitor signal inside it

Private equity firm Knox Lane is selling pharma consultancy Fingerpaint Group, Axios Pro has learned.Why it matters: Pharma marketing saw steady deal activity in the second half of 2025.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

boulder

detroit

kansas-city

columbus

austin

dallas

atlanta

washington-dc

nw-arkansas

chicago

indianapolis

nashville

richmond

colorado-springs

houston

san-francisco

seattle

boston

des-moines

salt-lake-city

philadelphia

denver

phoenix

new-orleans

miami

twin-cities

raleigh

san-antonio

portland

san-diego

tampa-bay

cleveland

huntsville

pittsburgh

axios-local

axios-pro

axios-live

the-axios-show

Scoop: Knox Lane-backed Fingerpaint Group on the block

What to read next